MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia

Keyphrases

• Pediatric Acute Lymphoblastic Leukemia 100%
• Genetic Diversity 100%
• MicroRNA 100%
• Drug Resistance 100%
• Genetic Drugs 100%
• Diversity Resistance 100%
• Acute Lymphoblastic Leukemia 50%
• MicroRNA Signature 37%
• TEL-AML1 25%
• Hyperdiploid 25%
• Leukemic Cells 12%
• L-asparaginase 12%
• C-Myc 12%
• Clinical Outcomes 12%
• Functional Studies 12%
• Protein-coding Genes 12%
• Expression Level 12%
• Cell Surface Display 12%
• T Cells 12%
• Daunorubicin 12%
• Oncoprotein 12%
• Quantitative PCR 12%
• Hematopoietic Cells 12%
• Pediatric Leukemia 12%
• 5-year Survival 12%
• Expression Profile 12%
• Genetic Subtypes 12%
• Bother 12%
• Prednisolone 12%
• Cytogenetic Aberrations 12%
• Precursor B-cell Acute Lymphoblastic Leukemia 12%
• Combined Expression 12%
• Let-7a 12%
• Novel microRNA 12%
• MiR-125b 12%
• MiR-100 12%
• MiR-99a 12%
• E2A-PBX1 12%
• Multidrug-resistant 12%
• BCR-ABL Positive 12%
• Hematopoietic Cancer 12%
• Display Characteristics 12%
• Forgoing 12%

Biochemistry, Genetics and Molecular Biology

• Genetic Divergence 100%
• MicroRNA 100%
• Drug Resistance 100%
• Pediatrics 100%
• Upregulation 16%
• Genetics 8%
• PBX1 8%
• B Cell 8%
• Precursor 8%
• T Cell 8%
• Asparaginase 8%
• Oncogene C Myc 8%
• Downregulation 8%
• Cytogenetics 8%
• Real-Time Polymerase Chain Reaction 8%
• Disease Free Survival 8%
• Daunorubicin 8%
• Hematopoietic Cell 8%
• Prednisolone 8%
• Expression Level 8%